|
FGD4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.41579999999963E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.844500E-04 |
| Normal-vs-Stage2 |
1.939720E-02 |
| Normal-vs-Stage3 |
1.70874999999571E-05 |
| Normal-vs-Stage4 |
4.01800000000563E-05 |
| Stage1-vs-Stage2 |
8.722200E-01 |
| Stage1-vs-Stage3 |
4.730300E-02 |
| Stage1-vs-Stage4 |
4.140100E-02 |
| Stage2-vs-Stage3 |
1.507160E-01 |
| Stage2-vs-Stage4 |
9.946400E-02 |
| Stage3-vs-Stage4 |
6.264000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.29510000000688E-05 |
| Normal-vs-AfricanAmerican |
4.242600E-04 |
| Normal-vs-Asian |
1.157790E-02 |
| Caucasian-vs-AfricanAmerican |
1.345980E-01 |
| Caucasian-vs-Asian |
7.701000E-01 |
| AfricanAmerican-vs-Asian |
1.857170E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.569000E-04 |
| Normal-vs-Female |
5.54809999999684E-05 |
| Male-vs-Female |
8.362400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.217000E-03 |
| Normal-vs-Age(41-60Yrs) |
3.83010000004624E-06 |
| Normal-vs-Age(61-80Yrs) |
4.214900E-04 |
| Normal-vs-Age(81-100Yrs) |
6.437700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.254500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.099400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.076770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.624400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.739600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.836800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.363600E-03 |
| Classical-VS-Follicular |
8.391200E-01 |
| Classical-VS-Other |
7.985800E-01 |
| Classical-VS-Normal |
2.776600E-04 |
| Tall-VS-Follicular |
3.103600E-02 |
| Tall-VS-Other |
2.740600E-01 |
| Tall-VS-Normal |
2.16500000005393E-06 |
| Follicular-VS-Other |
8.700400E-01 |
| Follicular-VS-Normal |
3.104800E-03 |
| Other-VS-Normal |
1.166800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.08219999999959E-05 |
| Normal-vs-N1 |
2.117200E-03 |
| N0-vs-N1 |
9.784200E-01 |
|
|
